Preventive Soliris Appears to Increase Kidney Transplant Success in aHUS

Preventive Soliris Appears to Increase Kidney Transplant Success in aHUS

291314

Preventive Soliris Appears to Increase Kidney Transplant Success in aHUS

Preventive or early treatment with Soliris (eculizumab) appears to increase the chances of a successful kidney transplant among people with atypical hemolytic uremic syndrome (aHUS), a new study reports. While limited by its small sample size, the study found that none of the patients treated with prophylactic (preventive) Soliris experienced an unsuccessful transplant, while about 20% of those who did not receive such treatment had their transplant fail. The study, “Prophylactic or Early Use of…

You must be logged in to read/download the full post.